Evidence map›Paper›PMID 29095442›Full record

ArticleNature protocols2017

A high-throughput in vivo screening method in the mouse for identifying regulators of metastatic colonization.

Anneliese O Speak, Agnieszka Swiatkowska, Natasha A Karp, Mark J Arends, David J Adams, Louise van der Weyden

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Nature protocols, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Anneliese O SpeakExperimental Cancer Genetics Group, Wellcome Trust Sanger Institute, Hinxton, UK.ORCID http://orcid.org/0000-0003-4890-4685
Agnieszka SwiatkowskaExperimental Cancer Genetics Group, Wellcome Trust Sanger Institute, Hinxton, UK.
Natasha A KarpExperimental Cancer Genetics Group, Wellcome Trust Sanger Institute, Hinxton, UK.
Mark J ArendsCancer Research UK Edinburgh Centre, Institute of Genetics & Molecular Medicine (IGMM), University of Edinburgh, Edinburgh, UK.
David J AdamsExperimental Cancer Genetics Group, Wellcome Trust Sanger Institute, Hinxton, UK.
Louise van der WeydenExperimental Cancer Genetics Group, Wellcome Trust Sanger Institute, Hinxton, UK.
Wellcome Sanger Institute · GBEdinburgh Cancer Research · GB

Funding

Cancer Research UK 13031
6 · The paper itself

Abstract

We describe a sensitive, robust, high-throughput method for quantifying the ability of metastatic tumor cells to colonize a secondary organ. Metastasis is the leading cause of death in cancer patients, and successful colonization of the secondary organ is the rate-limiting step in the metastatic process; thus, experimental methods that can be used to interrogate the key factors required for this critical step are of great importance. The experimental metastasis assay we detail here includes tail-vein injection of cancer cells into the mouse and determination of the resulting secondary organ colonization, primarily in the lung, 10 d post dosing. This assay can be used to investigate factors that regulate metastatic colonization both at the tumor-cell-intrinsic level (via manipulation of the tumor cells before injection) and at the tumor-cell-extrinsic level (such as the tissue microenvironment, via the use of genetically modified (GM) mice or agents such as antibodies or drugs). Using this method, we have robustly screened more than 950 GM mouse lines to identify novel microenvironmental regulators of metastatic colonization. The experimental details discussed here include choosing of appropriate cell numbers, handling of the cells, selection of recipient animals and injection techniques. Furthermore, we discuss key experimental design considerations, including the choice of the method used to determine metastatic burden and statistical analysis of the results, as well as provide troubleshooting tips and identification of factors that contribute to experimental variability.

Indexed as

High-Throughput Screening AssaysAnimalsBreast NeoplasmsCell Line, TumorColorectal NeoplasmsCRISPR-Cas SystemsFemaleGene EditingHumansInjections, IntravenousLung NeoplasmsMelanoma, ExperimentalMiceMice, TransgenicNeoplasm MetastasisNeoplasm Transplantation

Identifiers

PMID29095442
OpenAlexW2766278684

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.